Chemotherapy a Historical Review

Website http://www.onlinecompliancepanel.com?expDate=Ourglocal | Edit Freely

Category 508 compliance; act compliance; fda compliance; ada compliance; advisor compliance; argent software pci compliance; certificate of compliance; code compliance; compliance; compliance audit; compliance checklist; compliance issues; compliance jobs; compliance management; compliance manager; compliance manual; compliance monitoring; compliance monitoring ppt; compliance officer; compliance plan; compliance plans; compliance program; compliance software; compliance solutions; compliance testing; compliance training; compliance with; contract compliance; corporate compliance; email compliance; environmental compliance; export compliance; health care compliance; healthcare compliance; hipaa compliance; hippa compliance; investment advisor compliance; medical compliance; medication compliance; non compliance; osha compliance; osha compliance training; pci compliance; policy compliance; regulatory compliance; rohs compliance; safety compliance; sarbanes oxley compliance; security compliance; sox compliance; tax comp

Deadline: April 29, 2014 | Date: April 29, 2014

Venue/Country: 38868 Salmon Ter, Fremont, U.S.A

Updated: 2014-04-17 17:59:27 (GMT+9)

Call For Papers - CFP

Description:

The discovery that certain toxic chemicals administered in combination can cure certain cancers ranks as one of the greatest in modern medicine. Childhood ALL, testicular cancer, and Hodgkin's disease, previously universally fatal, are now generally curable diseases.

The early revolution in cancer therapy was largely a North American experience, powered by an optimistic and forward-looking United States Federal government, which funded the NCI with the same "big-idea" philosophy as the Apollo Space Program.

The era of cancer chemotherapy began in the 1940s with the first use of nitrogen mustards and folic acid antagonist drugs. Cancer drug development has exploded since then into a multi-billion dollar industry. The targeted therapy revolution has arrived, but many of the principles and limitations of chemotherapy discovered by the early researchers still apply.

Why Should you Attend:

To learn about the history of development of Chemotherapy.

Objectives of the Presentation:

The development of chemotherapy beginning with 1940-1950 discovery, through targeted therapy being developed in the modern age.

Who can Benefit:

Research Coordinators

Clinical Research Associates

Clinical Research Project Manager

Contract Research Organizations

Safety Nurses

http://www.onlinecompliancepanel.com/ecommerce/webinar/~product_id=500292?expDate=Ourglocal